SELLAS Life Sciences Group Inc (NASDAQ: SLS) on Tuesday, soared 2.50% from the previous trading day, before settling in for the closing price of $2.0. Within the past 52 weeks, SLS’s price has moved between $0.77 and $2.27.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 45.94%. The company achieved an average annual earnings per share of 41.33%. With a float of $103.11 million, this company’s outstanding shares have now reached $105.30 million.
Considering the fact that the conglomerate employs 15 people, you should pay attention to its efficiency factor.
SELLAS Life Sciences Group Inc (SLS) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of SELLAS Life Sciences Group Inc is 2.08%, while institutional ownership is 25.57%. The most recent insider transaction that took place on Jun 12 ’25, was worth 14,800. In this transaction Director of this company bought 10,000 shares at a rate of $1.48, taking the stock ownership to the 20,400 shares. Before that another transaction happened on May 30 ’25, when Company’s Director bought 20,000 for $1.69, making the entire transaction worth $33,800. This insider now owns 30,400 shares in total.
SELLAS Life Sciences Group Inc (SLS) Recent Fiscal highlights
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.1 earnings per share (EPS) for the period topping the consensus outlook (set at -0.13) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 41.33% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.63% during the next five years compared to 45.94% growth over the previous five years of trading.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) Trading Performance Indicators
SELLAS Life Sciences Group Inc (SLS) is currently performing well based on its current performance indicators. A quick ratio of 4.91 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.33, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach -0.36 in one year’s time.
